scispace - formally typeset
Open AccessJournal ArticleDOI

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

TLDR
In the EU, the highest age-standardised incidence rates for oesophageal cancer are in the Netherlands for men and the UK for women, and variation between countries is high and may reflect different prevalence of risk factors, use of screening and diagnostic methods.
About
This article is published in Annals of Oncology.The article was published on 2013-10-01 and is currently open access. It has received 810 citations till now. The article focuses on the topics: European union & Cancer.

read more

Citations
More filters
Journal ArticleDOI

The Effect of the Appropriate Timing of Radiotherapy on Survival Benefit in Patients with Metastatic Esophageal Cancer Who Have Undergone Resection of Primary Site: A SEER Database Analysis

TL;DR: For patients with MEC, preoperative radiotherapy might have a significant effect on the survival benefit over those who receive postoperatively radiotherapy, according to the cancer-specific survival (CSS) between the two groups.
Journal ArticleDOI

The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers—Review of the Literature

A. Secerov Ermenc, +1 more
- 29 May 2023 - 
TL;DR: The role of PET/CT and MRI in radiotherapy treatment planning for anal, esophageal, rectal and pancreatic cancer was summarized in this article , where they reported interobserver variability or changes in treatment planning volume due to different imaging modalities or correlation between the imaging modality and histopathologic specimen.
Journal ArticleDOI

Clinical impact and prognostic value of tumor infiltrating lymphocytes in esophageal squamous cell carcinoma

TL;DR: Tumour Infiltrating Lymphocytes can hence serve as a predictor for good prognosis of Esophageal Squamous Cell Carcinoma following surgery or radiotherapy/chemotherapy following surgery and radiotherapy.
Journal ArticleDOI

The Clinical Impacts of Neutrophil to Lymphocyte Ratio for Esophageal Cancer Patients Who Receive Curative Treatment

TL;DR: In this article, the authors investigated the impact of the neutrophil to lymphocyte ratio on esophageal cancer survival and recurrence after curative treatment and found that neutrophils to lymphocytes ratio of 2.38 was the optimal critical point of classification considering the 1-year, 3-year and 5-year survival rate.
Journal ArticleDOI

Facteurs dosimétriques liés aux complications pulmonaires postopératoires dans les cancers de l’œsophage localement avancés traités par radiochimiothérapie préopératoire : revue de la littérature

TL;DR: Les parametres dosimetriques associes aux complications pulmonaires postoperatoires les plus frequemment identifies sont le V20 et la dose pulmonaire moyenne, et cinq n’ont pas mis en evidence of correlation entre facteurs dosimetiques et taux de complications pul monaires post operatoires.
References
More filters
Journal ArticleDOI

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

TL;DR: In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival.
Journal ArticleDOI

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

TL;DR: Up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe.
Journal ArticleDOI

Hospital Volume and Surgical Mortality in the United States

TL;DR: Mortality decreased as volume increased for all 14 types of procedures, but the relative importance of volume varied markedly according to the type of procedure.
Journal ArticleDOI

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

TL;DR: Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer and the regimen was associated with acceptable adverse-event rates.
Related Papers (5)